InsidersTradesSigma
Follow the Fisher & Paykel Healthcare Corporation Limited stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares trade on the AU market, under the supervision of ASX. Operating in the Health Care sector, Fisher & Paykel Healthcare Corporation Limited has logged 1 public disclosures. Market capitalisation: €21bn. The latest transaction was disclosed on 18 May 2026 (Initial Substantial Holding). The full history is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Fisher & Paykel Healthcare Corporation Limited Buy (bullish), based on 9 analysts. Average price target: A$36.92.
Fundamental score
Ranked 8,755 of 29,063 companies
61.4
score / 100
Value37
Quality86
FCF yld2.2%
Earn yld2.2%
EV/EBITDA27.0x
ROE23%
Gross mgn64%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 May 2026
关于 Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited 是一家新西兰公司，专门从事呼吸和麻醉医疗设备的设计和制造。该公司在 XASX 市场上市。